Pfizer Files 8K - Other Events
February 03 2017 - 9:18AM
Dow Jones News
Pfizer Inc. (PFE) filed a Form 8K - Other Events - with the U.S
Securities and Exchange Commission on February 03, 2017.
On February 2, 2017, Pfizer Inc. ("Pfizer") entered into an
accelerated share repurchase agreement with Citibank N.A.
("Citibank") to repurchase $5 billion of Pfizer's common stock.
Approximately 126 million of the shares to be repurchased under the
transaction will be received by Pfizer on February 6, 2017.
At settlement of the agreement, which is expected to occur
during or prior to the third quarter of 2017, Citibank may be
required to deliver additional shares of Pfizer's common stock to
Pfizer, or, under certain circumstances, Pfizer may be required to
deliver shares of its common stock or may elect to make a cash
payment to Citibank, with the number of shares to be delivered or
the amount of such payment based on the volume-weighted average
price of Pfizer's common stock during the term of the
transaction.
This agreement was entered into pursuant to Pfizer's previously
announced share repurchase authorization.
The press release relating to the accelerated share repurchase
agreement is filed as an exhibit to this Form 8-K and is
incorporated herein by reference.
The full text of this SEC filing can be retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000007800317000004/n8k217.htm
Any exhibits and associated documents for this SEC filing can be
retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000007800317000004/0000078003-17-000004-index.htm
Public companies must file a Form 8-K, or current report, with
the SEC generally within four days of any event that could
materially affect a company's financial position or the value of
its shares.
(END) Dow Jones Newswires
February 03, 2017 09:03 ET (14:03 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024